Co-Diagnostics Submits FDA 510(k) for PCR Respiratory Test
Salt Lake City, Utah, USA, August 7, 2026 Co-Diagnostics, Inc. has reached a major regulatory milestone by submitting a...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Salt Lake City, Utah, USA, August 7, 2026 Co-Diagnostics, Inc. has reached a major regulatory milestone by submitting a...
SALT LAKE CITY, Utah, July 21, 2026 Seek Labs announced the publication of peer-reviewed research in Nature Communications validating...
TARPON SPRINGS, Fla., June 30, 2026 Allarity Therapeutics, Inc. announced that the U.S. Patent and Trademark Office (USPTO) has...
NEW YORK, June 16, 2026 Intelligent Bio Solutions (INBS) announced the initiation of a critical clinical Interference Study designed...
PEACHTREE CORNERS, Ga., June 2026 Guided Therapeutics, Inc. announced the submission of its Premarket Approval (PMA) clinical report to...
NEW YORK | December 31, 2025 — Intelligent Bio Solutions announced a strategic manufacturing partnership with Syrma Johari MedTech,...
New York, NY — November 20, 2025 — Aidoc, a global leader in clinical artificial intelligence, announced a major...
